Isaac Blum has served as Senior Manager of Clinical Supply at ALX Oncology since June 2021. Previously, Isaac served in operational roles of increasing responsibility at BioMarin Pharmaceutical, Sangamo Therapeutics and Puma Biotechnology. Isaac is excited about developing global supply strategies and systems to help advance innovative, life-saving treatments. He has used his expertise to launch multiple global oncology clinical trials, and has shared his expertise at numerous speaking events. Isaac holds a B.A. from the University of Puget Sound.